Sirio Pharma

Activities: Manufacturing Packaging Research & Development Dosage Forms

Trending Articles

  1. Counteracting counterfeits in the pharmaceutical supply chain Sreedhar Patnala, General Manager at Systech, discusses the comprehensive benefits of embracing traceability
  2. Olon commits to ultra-potent compound manufacturing expansion with new €25m facility The CDMO's integrated small and large-scale lines can produce payloads, linker payloads and ultra-potent APIs for customers across Europe
  3. Neogap Therapeutics and NorthX Biologics team up to scale novel cancer cell therapy CDMO NorthX Biologics will work with Neogap to determine advanced manufacturing protocols for Neogap's personalised cancer cell therapy
  4. New kinase inhibitor shows promise for treatment-resistant malaria The single-dose drug may be more effective than current treatments on the market, and works by disabling Plasmodium's ability to splice RNA
  5. Novo Nordisk acquires license to Ascendis Pharma's TransCon tech for up to $286m Novo Nordisk will use the technology to develop, manufacture and commercialise therapeutics for metabolic and cardiovascular diseases

Upcoming event

CPhI India

26–28 November 2024 | Online Conference & Networking | Delhi, India See all

Related Content

Manufacturing

Sirio Pharma targets consumer health at CPHI Barcelona

The pharmaceutical company is set to appear at CPHI Barcelona and showcase three ingredients to help maintain eye health, with new ready-to market formulations
Design & Build

Sirio Europe invests in Brandenburg site

The plant upgrades form a part of a wider drive at Sirio to implement sustainable manufacturing processes, the company says
Manufacturing

Sirio Pharma eyes global R&D collaboration

China's CDMO plans to combine the expertise of its 100+ scientist based in Asia, Europe and the US
Subscribe now